期刊文献+

保乳手术与改良根治术对早期乳腺癌治疗效果的影响研究 被引量:8

Influence of breast-conserving surgery and modified radical mastectomy for early breast cancer treatment
在线阅读 下载PDF
导出
摘要 目的探讨保乳手术与改良根治术对早期乳腺癌治疗效果的影响。方法将我院2008年1月~2012年1月行保乳手术治疗的36例早期乳腺癌患者设立为A组,另选择同期行改良根治术治疗的32例乳腺癌患者设立为B组。结果 A组手术时间短于B组,术中出血量少于B组、术后住院时间短于B组,A组并发症发生率明显低于B组,差异有统计学意义(P<0.05),两组1年生存率以及局部复发率比较,差异无统计学意义(P>0.05)。结论保乳手术治疗早期乳腺癌的效果明显优于改良根治术,值得推广和应用。 Objective To investigate the impact of breast-conserving surgery and modified radical mastectomy for early breast cancer. Methods 36 cases of early breast cancer patients in the hospital from January 2008 to January 2012 by breast-conserving surgery set up for group A, and the same period in modified radical treatment 32 patients with breast cancer established as B group. Results A group of surgical time was shorter than group B, blood loss was less than group B, postoperative hospital stay was shorter than group B, the complications incidence of group A was significantly lower than group B, the difference was statistically significant(P 〈 0.05 ), followed 1-year survival and local recurrence rate between two groups had no statistically significant difference (P 〉 0.05). Conclusion The effect of breast-conserving surgery for early breast cancer is significantly better than modified radical mastectomy, and it worthy of promotion and application.
作者 柯德志
出处 《中国现代医生》 2012年第21期35-36,共2页 China Modern Doctor
关键词 早期乳腺癌 保乳手术 改良根治术 Early breast cancer Breast-conserving surgery Modified radical mastectomy
  • 相关文献

参考文献6

二级参考文献27

  • 1秦贤举,张华,罗文杰.影响乳腺癌保乳术后乳房外形的因素分析[J].中国临床医学,2005,12(5):806-808. 被引量:12
  • 2洪坚善,杨建荣,张传珉,刘剑伦,杨南武,陈建思,杨华伟.乳腺癌保乳手术的治疗及预后[J].中国普通外科杂志,2005,14(9):664-666. 被引量:7
  • 3张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:247
  • 4黄海林,王为民,蔡清萍,王强.早期乳腺癌保乳手术探讨[J].中国普通外科杂志,2006,15(4):241-243. 被引量:20
  • 5Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med,2002,347(16) :1233-1235.
  • 6Valagussa P, Zambetti M, Zucali R, et al. Neoadjuvamt chemothera- py colloque[J]. Inserm, 1998,169 : 123-127.
  • 7Clark RM, Me Culloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer [J]. J Natl Cancer Inst,1992,84(6) :683-685.
  • 8Staradub VL,Hsieh Clauson,et al.Factors that influence surgical choices in women with breast carcinoma.Cancer,2005,9(5):1185-1190.
  • 9Fish B, Bauer M, Maugolese R,et al. Five-year results of a random- ized Clinical trial comparing tot al mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med, 1985,312( 13 ) :665-673.
  • 10Dhindsa R S, Wandekayi Matowe. Drought tolerance in two mosses: Correlated enzymatic defence against lipid peroxidation. J Exp Bot, 1981, 32(126):79

共引文献68

同被引文献73

  • 1Danko ME, Bennett KM, Zhai J, et al. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up[J]. J Am Coll Surg, 2010, 210(5): 797-805.e1, 805-807.
  • 2Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16): 1233-1241.
  • 3Moerland MA, Wijrdeman HK, Beersma R, et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging[J]. Int J Radiat Oncol Biol Phys, 1997, 37(4): 927-933.
  • 4Woodward WA, Strom EA, Tucker SL, et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Impli-cations for breast cancer patients with early-stage disease and pre-dictors for recurrence after postmastectomy radiation[J]. Int J Radiat Oncol Biol Phys, 2003, 57(2):336-344.
  • 5Veronesi U, Zurrida S, Viale G, et al. Rethinking TNM: a breastcancer classification to guide to treatment and facilitate research[J].Breast J, 2009, 15(3):291-295.
  • 6Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant ra-diotherapy[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5):1337-1347.
  • 7Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503): 2087-2106.
  • 8Nielsen HM, Overgaard M, Grau C, et al. Loco-regional recur-rence after mastectomy in high-risk breast cancer-risk and progno-sis. An analysis of patients from the DBCG 82 b&c randomization trials[J]. Radiother Oncol, 2006, 79(2):147-155.
  • 9Blumgart EI, Uren RF, Nielsen PM, et al. Predicting lymphatic drain- age patterns and primary tumour location in patients with breastcancer [ J ]. Breast Cancer Res Treat,2011,130 ( 2 ) : 699 - 705.
  • 10Sun J, Yin J, Ning L, et al. Clinicopathological characteristics of breast cancers with axillary skip metastases [ J 1. J Invest Surg,2012, 25(1) :33 -36.

引证文献8

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部